← Every company

BridgeBio Pharma Inc SEC Filings

What BridgeBio Pharma Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

BBIO overview →
Filings on file
111
since May 24, 2019
Warning signs
0
none filed
Last results
Aug 10, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Jun 26, 2026
Executive or director changeShareholder vote
8-K
Read ↗
Mar 17, 2025
Executive or director change
8-K
Read ↗
Jul 23, 2024
Executive or director change
8-K
Read ↗
Feb 23, 2023
Executive or director changeResults announced
8-K
Read ↗
Oct 26, 2021
Executive or director change
8-K
Read ↗
Aug 23, 2021
Executive or director change
8-K
Read ↗
Jan 4, 2021
Executive or director change
8-K
Read ↗
Oct 23, 2020
Executive or director change
8-K
Read ↗
Jun 24, 2020
Executive or director change
8-K
Read ↗
Jun 8, 2020
Executive or director changeShareholder vote
8-K
Read ↗
Feb 19, 2020
Executive or director change
8-K
Read ↗
Dec 17, 2019
Executive or director change
8-K
Read ↗
Oct 11, 2019
Executive or director change
8-K
Read ↗

Source: BridgeBio Pharma Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on BBIO

Related datasets